WallStreetZenWallStreetZen

NASDAQ: LNSR
Lensar Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LNSR

Based on 1 analyst offering 12 month price targets for Lensar Inc

Min Forecast
$10.00+79.86%
Avg Forecast
$10.00+79.86%
Max Forecast
$10.00+79.86%

Should I buy or sell LNSR stock?

Based on 1 analyst offering ratings for Lensar Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LNSR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LNSR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LNSR stock forecasts and price targets.

LNSR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-18

1 of 1

Forecast return on equity

Is LNSR forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is LNSR forecast to generate an efficient return on assets?

Company
-5.79%
Industry
10.83%
LNSR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LNSR earnings per share forecast

What is LNSR's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.31
Avg 2 year Forecast
-$0.34

LNSR revenue forecast

What is LNSR's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$64.3M+10.06%
Avg 2 year Forecast
$78.1M+33.62%
LNSR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LNSR revenue growth forecast

How is LNSR forecast to perform vs Medical Devices companies and vs the US market?

Company
10.06%
Industry
9.57%
Market
166.93%
LNSR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LNSR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LNSR vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
LNSR$5.56$10.00+79.86%Strong Buy
SRTS$3.96$6.00+51.52%Strong Buy
POAS$2.29N/AN/A
MDAI$2.27$3.00+32.16%Strong Buy
BDMD$1.80N/AN/A
View Top Medical Device Stocks

Lensar Stock Forecast FAQ

Is Lensar Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LNSR) stock is to Strong Buy LNSR stock.

Out of 1 analyst, 1 (100%) are recommending LNSR as a Strong Buy, 0 (0%) are recommending LNSR as a Buy, 0 (0%) are recommending LNSR as a Hold, 0 (0%) are recommending LNSR as a Sell, and 0 (0%) are recommending LNSR as a Strong Sell.

If you're new to stock investing, here's how to buy Lensar stock.

What is LNSR's earnings growth forecast for 2026-2027?

(NASDAQ: LNSR) Lensar's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 52.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,318.15%.

Lensar's earnings in 2026 is -$34,282,000.On average, 4 Wall Street analysts forecast LNSR's earnings for 2026 to be -$3,762,951, with the lowest LNSR earnings forecast at -$6,282,471, and the highest LNSR earnings forecast at -$1,016,033.

In 2027, LNSR is forecast to generate -$4,133,077 in earnings, with the lowest earnings forecast at -$8,416,140 and the highest earnings forecast at $508,017.

What is LNSR's revenue growth forecast for 2026-2027?

(NASDAQ: LNSR) Lensar's forecast annual revenue growth rate of 10.06% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 166.93%.

Lensar's revenue in 2026 is $58,435,000.On average, 4 Wall Street analysts forecast LNSR's revenue for 2026 to be $777,882,125, with the lowest LNSR revenue forecast at $707,666,987, and the highest LNSR revenue forecast at $843,307,393.

In 2027, LNSR is forecast to generate $944,438,964 in revenue, with the lowest revenue forecast at $757,452,604 and the highest revenue forecast at $1,132,876,799.

What is LNSR's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: LNSR) forecast ROA is -5.79%, which is lower than the forecast US Medical Devices industry average of 10.83%.

What is LNSR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LNSR price target, the average LNSR price target is $10.00, with the highest LNSR stock price forecast at $10.00 and the lowest LNSR stock price forecast at $10.00.

The Wall Street analyst predicted that Lensar's share price could reach $10.00 by Mar 18, 2027. The average Lensar stock price prediction forecasts a potential upside of 79.86% from the current LNSR share price of $5.56.

What is LNSR's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: LNSR) Lensar's current Earnings Per Share (EPS) is -$2.87. On average, analysts forecast that LNSR's EPS will be -$0.31 for 2026, with the lowest EPS forecast at -$0.52, and the highest EPS forecast at -$0.08. In 2027, LNSR's EPS is forecast to hit -$0.34 (min: -$0.70, max: $0.04).

What is LNSR's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: LNSR) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.